Tocilizumab - Wikipedia

Tocilizumab, also known as atlizumab, is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis ...

Tocilizumab – Wikipedia

Klinische Angaben Anwendungsgebiete Rheumatoide Arthritis. Tocilizumab ist, in Kombination mit Methotrexat (MTX), für die Behandlung erwachsener Patienten mit ...

Rheumatoid Arthritis Treatment | ACTEMRA® (tocilizumab)

Learn about ACTEMRA® (tocilizumab), a treatment option for moderate to severe rheumatoid arthritis. See full safety for more information.

Tocilizumab - Informazioni sui farmaci

Tocilizumab è un nuovo farmaco biologico per uso endovenoso che inibisce la citochina pro-infiammatoria interleukina-6. Associato al metotrexato si è dimostrato ...

Trial of Tocilizumab in Giant-Cell Arteritis | NEJM

BackgroundGiant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolonged use of glucocorticoids is associated with side effects. The ...

Tocilizumab monotherapy versus adalimumab monotherapy for ...

Background. Roughly a third of patients with rheumatoid arthritis treated with biological treatments receive them as monotherapy. Tocilizumab—an inhibitor of ...

Tocilizumab for treating giant cell arteritis | Guidance ...

Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults

RoActemra 20mg/ml Concentrate for Solution for Infusion ...

RoActemra 20mg/ml Concentrate for Solution for Infusion - Summary of Product Characteristics (SmPC) by Roche Products Limited

Adalimumab, etanercept, infliximab, certolizumab pegol ...

NICE Guidance; Conditions and diseases; Musculoskeletal conditions; Arthritis; Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and ...

LusiNEX (tocilizumab) | 永昕生物醫藥

LusiNEX為生物相似藥(原廠生物藥：Actemra®/ RoActemra®)，能與第六介白素受體(IL-6R)結合，藉以阻斷IL-6的作用，達到抗發炎與調節 ...